Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaus

Showing results (1-10 of 760) with videos related to

Pageof 76
Sort By:
Journal of Colloid and Interface Science|August 12, 1999
Surface Plasmon Resonance Measurement of the Binding of Low-Density Lipoprotein at a Heparin SurfaceGaus, Hall
Health Systems Review|December 8, 1996
From theory to practice: AHCPR's new missionC Gaus
Forschende Komplementarmedizin Und Klassische Naturheilkunde = Research in Complementary and Natural Classical Medicine|September 9, 2004
Randomised trials versus observational studies: is the comparative observational study a poor compromise or a perfect synthesis?W Gaus
Aktuelle Probleme in Chirurgie Und Orthopadie|January 1, 1981
[Need and goals for documentation - illustrated using the example of brain tumors]W Gaus
Biophysical Journal|August 26, 2016
Biologists Wanted: New Fluorescence Fluctuation Tools for Cell BiologyKatharina Gaus
International Journal of Geriatric Psychiatry|January 21, 2009
An example for an underpowered study: a comment on Ginkgo biloba for mild to moderate dementia in a community setting by McCarney et alWilhelm Gaus
Journal of Colloid and Interface Science|December 17, 1997
Evaluation of Surface Plasmon Resonance (SPR) for Heparin AssayGaus, Hall
Business and Health|March 9, 1995
Washington's new guidelines guru. Interview by Geoffrey LeavenworthC Gaus
The Johns Hopkins Medical Journal|January 1, 1971
Who enrolls in a prepaid group practice: the Columbia experienceC Gaus
Toxicology Letters|July 8, 2014
Which level of evidence does the US National Toxicology Program provide? Statistical considerations using the Technical Report 578 on Ginkgo biloba as an exampleWilhelm Gaus
Pageof 76

Showing results (1-10 of 760) with videos related to

Sort By:
Pageof 76
Journal of Colloid and Interface Science|August 12, 1999
Surface Plasmon Resonance Measurement of the Binding of Low-Density Lipoprotein at a Heparin SurfaceGaus, Hall
Health Systems Review|December 8, 1996
From theory to practice: AHCPR's new missionC Gaus
Forschende Komplementarmedizin Und Klassische Naturheilkunde = Research in Complementary and Natural Classical Medicine|September 9, 2004
Randomised trials versus observational studies: is the comparative observational study a poor compromise or a perfect synthesis?W Gaus
Aktuelle Probleme in Chirurgie Und Orthopadie|January 1, 1981
[Need and goals for documentation - illustrated using the example of brain tumors]W Gaus
Biophysical Journal|August 26, 2016
Biologists Wanted: New Fluorescence Fluctuation Tools for Cell BiologyKatharina Gaus
International Journal of Geriatric Psychiatry|January 21, 2009
An example for an underpowered study: a comment on Ginkgo biloba for mild to moderate dementia in a community setting by McCarney et alWilhelm Gaus
Journal of Colloid and Interface Science|December 17, 1997
Evaluation of Surface Plasmon Resonance (SPR) for Heparin AssayGaus, Hall
Business and Health|March 9, 1995
Washington's new guidelines guru. Interview by Geoffrey LeavenworthC Gaus
The Johns Hopkins Medical Journal|January 1, 1971
Who enrolls in a prepaid group practice: the Columbia experienceC Gaus
Toxicology Letters|July 8, 2014
Which level of evidence does the US National Toxicology Program provide? Statistical considerations using the Technical Report 578 on Ginkgo biloba as an exampleWilhelm Gaus
Pageof 76